Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population

Hesham N. TarrafDepartment of Internal Medicine, Cairo University, Cairo, Egypt; Correspondence[email protected]

, MD,

Hossam Hosny MasoudPulmonology Department (Chest), Cairo University, Cairo, Egypt;

, MD,

Mohamed ZidanChest Diseases Department, Alexandria University, Alexandria, Egypt;

, MD &

Begad WahbaNovartis Pharma S.A.E., Cairo, Egypt

, MD

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Didier Cataldo, Renaud Louis, Alain Michils, Rudi Peché, Charles Pilette, Florence Schleich, Vincent Ninane & Shane Hanon. (2021) Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways. Journal of Asthma 58:4, pages 448-458.
Read now

Articles from other publishers (4)

Christos Kyriakopoulos, Athena Gogali, Georgios Markozannes & Konstantinos Kostikas. (2024) Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials. European Respiratory Review 33:172, pages 230238.
Crossref

Antonio Nieto, Zeinab A. El-Sayed, René Maximiliano Gómez, Elham Hossny, Wang Jiu-Yao, Ömer Kalayci, Mário Morais-Almeida, Wanda Phipatanakul, Paulo Marcio Pitrez, César Fireth Pozo Beltrán, Paraskevi Xepapadaki & Nikolaos G. Papadopoulos. (2023) Unanswered questions on the use of biologics in pediatric asthma. World Allergy Organization Journal 16:11, pages 100837.
Crossref

Lu Cheng, Tianrui Yang, Xiang Ma, Yuling Han & Yongtai Wang. (2021) Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma. Journal of Pharmacy Practice, pages 089719002110382.
Crossref

Antonio Nieto García, Teresa Garriga‐Baraut, Ana María Plaza Martín, María Nieto Cid, Javier Torres Borrego, María del Mar Folqué Giménez, Jaime Lozano Blasco, Montserrat Bosque García, Laura Moreno‐Galarraga, Miguel Tortajada‐Girbés, Cristina Rivas Juesas, María Penín Antón, María Araceli Caballero‐Rabasco, Mirella Gaboli, Alejandro López Neyra, Juan Navarro Morón, Andrea Freixa Benavente, Laura Valdesoiro Navarrete, Esther Ballester Asensio, Verónica Sanz Santiago, Raquel Romero García, Álvaro Gimeno Díaz de Atauri, Alfredo Valenzuela Soria, Mercedes Sánchez Mateos, José Batlles Garrido, Anselmo Andrés Martín, Elena Campos Alonso, Carmen Aragón Fernández, Elena Vázquez Rodríguez, Luz Martínez Pardo, Genoveva del‐Río Camacho & Ángel Mazón Ramos. (2021) Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma. Pediatric Allergy and Immunology 32:5, pages 980-991.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population

Citations (5)

Read on this site (1)

Articles from other publishers (4)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date